RNAi Knockdown of EHMT2 in Maternal Expression of Prader–Willi Syndrome Genes
Genes · 2024
DOI: 10.3390/genes15111366 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2024. Verfasst von Violeta Zaric und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, UT Southwestern Medical Center, Dallas, TX 75390, USA. Hauptthemen laut MEDLINE: Prader-Willi Syndrome, Induced Pluripotent Stem Cells, Histone-Lysine N-Methyltransferase, RNA, Small Nucleolar. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, Foundation for Prader-Willi Research, Taysha Gene Therapies, Inc..
Abstract (Originalsprache)
Background/objectives: Euchromatic histone lysine methyltransferase 2 (EHMT2, also known as G9a) is a mammalian histone methyltransferase that catalyzes the dimethylation of histone 3 lysine 9 (H3K9). On human chromosome 15, the parental-specific expression of Prader–Willi Syndrome (PWS)-related genes, such as SNRPN and SNORD116, are regulated through the genetic imprinting of the PWS imprinting center (PWS-IC). On the paternal allele, PWS genes are expressed whereas the epigenetic maternal silencing of PWS genes is controlled by the EHMT2-mediated methylation of H3K9 in PWS-IC. Here, we measured the effects of RNA interference of EHMT2 on the maternal expression of genes deficient in PWS in mouse model and patient iPSC-derived cells.
Methods
We used small interfering RNA (siRNA) oligonucleotides and lentiviral short harpin RNA (shRNA) to reduce Ehtm2/EHMT2 expression in mouse Snord116 deletion primary neurons, PWS patient-derived induced pluripotent stem cell (iPSC) line and PWS iPSC-derived neurons. We then measured the expression of transcript or protein (if relevant) of PWS genes normally silenced on the maternal allele.
Results
With an approximate reduction of 90% in EHMT2 mRNA and more than 80% of the EHMT2 protein, we demonstrated close to a 2-fold increase in the expression of maternal transcripts for SNRPN and SNORD116 in PWS iPSCs treated with siEHMT2 compared to PWS iPSC siControl. A similar increase in SNORD116 and SNRPN RNA expression was observed in PWS iPSC-derived neurons treated with shEHMT2.
Conclusions
RNAi reduction in EHMT2 activates maternally silenced PWS genes. Further studies are needed to determine whether the increase is therapeutically relevant. This study confirms the role of EHMT2 in the epigenetic regulation of PWS genes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, UT Southwestern Medical Center, Dallas, TX 75390, USA.
- Department of Pediatrics, UT Southwestern Medical Center, Dallas, TX 75390, USA.
- O'Donnell Brain Institute, UT Southwestern Medical Center, Dallas, TX 75390, USA.
- Center for Hypothalamic Research, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX 75390, USA.
ORCID-Profile: Volodymyr Rybalchenko, Steven J Gray, Ryan K Butler
Förderung
- NIDDK NIH HHS
- Foundation for Prader-Willi Research
- Taysha Gene Therapies, Inc.
- Foundation for Prader–Willi Research
Zitieren
APA
Zaric, V., Kang, H. R., Rybalchenko, V., Zigman, J. M., Gray, S. J., & Butler, R. K. (2024). RNAi Knockdown of EHMT2 in Maternal Expression of Prader–Willi Syndrome Genes. Genes. https://doi.org/10.3390/genes15111366
Vancouver
Zaric V, Kang HR, Rybalchenko V, Zigman JM, Gray SJ, Butler RK. RNAi Knockdown of EHMT2 in Maternal Expression of Prader–Willi Syndrome Genes. Genes. 2024. doi:10.3390/genes15111366
BibTeX
@article{Zaric2024,
author = {Zaric, Violeta and Kang, Hye Ri and Rybalchenko, Volodymyr and Zigman, Jeffrey M and Gray, Steven J and Butler, Ryan K},
title = {RNAi Knockdown of EHMT2 in Maternal Expression of Prader–Willi Syndrome Genes},
journal = {Genes},
year = {2024},
doi = {10.3390/genes15111366}
}
EUVIMED